PTC Therapeutics completes $200m acquisition of Agilis Biotherapeutics to expand gene therapy portfolio

In a major strategic move, US biopharmaceutical company PTC Therapeutics has finalized its acquisition of Agilis Biotherapeutics, a biotech firm specializing in the development of ... Read More